Samia Al-Amoudi, MBBch, CABOG
Chairwoman of Sheikh Mohammed H. Al-Amoudi Chair of Women's Health Empowerment at King Abdulaziz University, Jeddah, Saudi Arabia
CEO and Board Member, Sheikh Mohammed Hussein Al-Amoudi Center of Excellence in Breast Cancer, Scientific Chair for Breast Cancer
Associate Professor and Consultant Obstetrician Gynecologist, King Abdulaziz University, Jeddah, Saudi Arabia
Dr. Samia Al-Amoudi is an Associate Professor at King Abdulaziz University in Jeddah (KAU) and a Consultant Obstetrician Gynecologist. She is head of Sheikh Mohammed Hussein Al-Amoudi Center of Excellence in breast cancer and scientific chair for breast cancer at KAU, Jeddah Saudi Arabia. Previously she has worked as Vice Dean of the College of Medicine and Allied Sciences at King Abdulaziz University; a Temporary Advisor for a 1995 Inter-country workshop on Reproductive Health and Research Methodology at the World Health Organization; and Director of the Dr. Samia Al-Amoudi Medical Center. In 1981, she was among the first group of female medical graduate from King Abdulaziz University.
She is a single parent and mother of one son, Abdullah, 19 years of age, and one daughter, Esraa, 15 years of age. In April 2006 she was diagnosed with breast cancer, now a six year survivor. She was the first Saudi to share her personal battle with the disease, breaking the silence to speak out about its impact. Dr. Samia Al-Amoudi is the author of 13 books. Her publications include Break the Silence, 2nd edition (in English) and My Journey with Breast Cancer (in Arabic) and Breast cancer survivors in Saudi Arabia in English. Her children wrote 2 books about breast cancer. She has participated in several print, radio, and television programs, including CNN in Jan 2009 in vital signs and ABC’s Good Morning America and USA Ch 9. Dr. Al-Amoudi has received a number of awards. In March 2007, the U.S Department of State awarded her the first International Women of Courage Award in recognition of her breast cancer awareness campaign and for sharing her personal battle with breast cancer to raise awareness across the Kingdom and throughout the Middle East.
In October 24 she was the facilitator of the former first lady of USA Laura Bush during her meeting with breast cancer survivors in Jeddah during her visit to Saudi Arabia. On 15th January 2008 she had been invited to Riyadh to meet the former President of USA during his visit to Saudi Arabia where he showed his and his wife appreciation and support to her work. She was honored by Susan G. Komen for the Cure® in March 2008 in Washington DC. On August 23rd, 2008 she was honored and received award ALMIFTAHA from Prince Faisal bin Khaled of Asir region in recognition of her work and efforts to raise public awareness in breast cancer.Her story is included in the secondary schools English curriculum in 2008 (people who made a difference). A Doc film about her story with breast cancer (break the silence) was aired by alarabia news TV ch on March 30, 2009.
In April 2009, she was honored by Princess Al Anood bint Abdullah, wife of Amir of Mecca region Prince Khaled AlFaisal, for her dedicated and pioneering work for her country and her community. On May 13, 2009 she received medal of courage from Saudi Cancer foundation in Dammam, Saudi Arabia and patronage of HRH princess Jwaher Bint Naief Bin Abdulaziz. June 2009 she was invited as Komen Global Advocate to participate in race for the cure in Washington DC and was invited by President Obama's vice president Joe Biden and his wife Dr. Biden with the group of global Advocate. In October 2009 she was invited as Global Advocate in first care for the cure in Egypt and in support training workshop. She was invited in November 2009 by Harvard University and presented a talk about Barriers to breast cancer screening in Arab world. On 27th March 2010 she was nominated by Arabian business magazine among the most top 100 who have impact and made changes in their societies she rank the 5th in Arab world and first women in Saudi Arabia in this list. She established the first Breast Cancer Center of Excellency in the region at King Abdulaziz University in Jeddah Saudi Arabia, now in operation since 2010.
Maureen Kelley, Ph.D.
Assistant Professor of Bioethics, Department of Pediatrics, University of Washington School of Medicine and Treuman Katz Center for Pediatric Bioethics, Seattle Children's
Affiliated faculty UW Center for Human Rights and UW Global Center for Integrated Health of Women, Adolescents, and Children
Maureen Kelley is a bioethicist, working in maternal, neonatal and child health. She is Assistant Professor in the Department of Pediatrics, in the Division of Bioethics, at the University of Washington School of Medicine. She holds joint appointments on the faculty at the Treuman Katz Center for Pediatric Bioethics and the Global Alliance to Prevent Prematurity and Stillbirth at Seattle Children’s Research Institute. Dr. Kelley also serves on the affiliated faculty at the University of Washington’s Center for Human Rights and is a member of the new UW Global Center for Integrated Health of Women, Adolescents and Children. She earned her Ph.D. in Philosophy with a specialization in bioethics, at Rice University and completed her clinical bioethics training at Baylor College of Medicine’s program in Medical Ethics and Health Policy. She has held faculty appointments at Baylor College of Medicine and the University of Alabama, Sparkman Center for Global Health. Dr. Kelley conducts qualitative research and uses ethical argument to inform policy change and clinical practice, and has published on a range of ethical issues in maternal and child health and international research ethics. She has helped develop research and clinical ethics programs in resource-poor settings, with special attention to women and children, in Siberia, Zambia, Fiji, and Uganda.
Beth Rivin, MD, MPH
Director, Global Health and Justice Project
Research Associate Professor, Law
Adjunct Research Associate Professor, Global Health and Bioethics and Humanities
University of Washington
Vice President, Programs
Professor Rivin directs the Global Health and Justice Project, a multidisciplinary project that is based at the UW School of Law. The project encompasses academic activities at UW as well as field activities in developing countries in collaboration with the Seattle-based NGO, Uplift International. She is a co-investigator on the International Biomedical Research Ethics Fellowship Grant, funded by the NIH Fogarty International Center. Professor Rivin co-directs the Certificate in International Bioethics, Social Justice and Health. In addition to her appointment at the Law School, Dr. Rivin has appointments in the Schools of Medicine and Public Health. She is Adjunct Research Associate Professor of Global Health and Bioethics and Humanities. Dr. Rivin is also faculty in the UW’s Center for Human Rights and was recently appointed a visiting professor at the University of Gadjah Mada in Indonesia, where she spent six months as a Fulbright Senior Scholar.
Dr. Rivin has worked in global health and development for 30 years. Her professional experience ranges from clinical pediatrics and adolescent medicine to field research, epidemiology, emergency humanitarian assistance and public health and human rights program development and evaluation. In addition to U.S. domestic work, Professor Rivin has field experience in China, Cambodia, Haiti, India, Indonesia, Israel, Nepal, the Philippines, Puerto Rico, Sri Lanka, Vietnam and Tajikistan. She has consulted with Ministries of Health, large governmental and international organizations, such as the U.S. Agency for International Development, the World Health Organization, and various non-governmental organizations. Dr. Rivin also has been instrumental in forming a global network of universities, launched at the 2012 World Congress of Bioethics, aimed at building clinical and research ethics capacity in medical schools in Asia.
President, Susan G. Komen for the Cure®
Elizabeth “Liz” Thompson was named president of Susan G. Komen for the Cure® in September 2010 after serving as Komen for the Cure’s senior vice president of medical and scientific affairs. She is a highly respected leader in the global cancer community, recognized for her passion for driving innovation in science and medicine as well as her expertise in formulating educational and public policy initiatives focused on quality and outcomes. As president, she leads the organization’s efforts to save lives and end breast cancer forever by empowering people, ensuring quality care for all and energizing science to find the cures. Her leadership has been significant in the organization’s investment of more than $1.9 billion since inception in breast cancer research, education, screening and treatment for breast cancer. As senior vice president of medical and scientific affairs, Thompson led the organization’s global research portfolio with more than $289 million in current, active grants; community investments of more than $98 million last year alone; management of Komen’s lauded Scientific Advisory Board and Scientific Advisory Council, and oversight of the organization’s global mission growth strategies. She serves as Komen’s voice on numerous external boards, review panels and committees.
A well-known expert in the cancer health arena, Thompson joined Komen in 2008 as managing director, public and medical affairs. She has overseen the organization's strategic relationships with large associations, community education and outreach programs, and global outreach strategies. She has excelled in initiating, developing and managing innovative programs in breast cancer research while maximizing the promise of Komen for the Cure. Her oversight of Komen’s education portfolio has involved direct patient education and specific initiatives that impact patient care, access and outcomes, such as clinical trials, regulatory controls, FDA issue management and interfacing with the National Cancer Institute.
Thompson’s interest in health and medicine began with what she calls her "first life" in medical publishing, traveling the world learning and working firsthand with top medical experts to produce educational materials (books, journals, CDs) about the trends, techniques and therapies that could and would make a difference for patients. Wanting to make more of a direct impact on patients and families, Thompson put her considerable management and marketing experience to work in the cancer advocacy arena. Her focus has been on leading and directing advocacy efforts to advance a deeper direct investment in cancer research, mobilizing grassroots lobbying and working to harness the power of thought leaders and coalitions to achieve breakthroughs in cancer research. Thompson has a Bachelor of Science from the University of South Dakota where she was in the Tom Brokaw School of Communications. As president, she reports to Komen founder and CEO Nancy G. Brinker.
Nana A. Y. Twum-Danso, MD, MPH, FACPM
Senior Program Officer, Family Health Division, Bill & Melinda Gates Foundation
Adjunct Assistant Professor, Department of Maternal and Child Health, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
Dr. Nana A. Y. Twum‐Danso is the Senior Program Officer for Community Health Solutions in the Family Health Division of the Bill & Melinda Gates Foundation. She is responsible for designing, developing and managing an innovative grants program to implement community‐based programs in support of the division’s strategic priorities. Dr. Twum‐Danso has more than ten years of experience in global health policy, strategy, program development, project management, monitoring and evaluation. She has technical expertise in quality improvement (QI), change management, health systems strengthening, community‐based health care delivery, maternal, neonatal and child health (MNCH), parasitic disease control, pharmacovigilance, and road traffic safety. She has lived and worked in Cameroon, Ghana, Pakistan and the USA.
Prior to joining the Foundation, Dr. Twum‐Danso worked at the Institute for Healthcare Improvement (IHI), a nonprofit organization based in Cambridge, Massachusetts, USA, for four years. She was initially the Director of Project Fives Alive!, a partnership between IHI and the National Catholic Health Service (NCHS) to accelerate the reduction of child mortality in Ghana through the application QI methods nationwide. In this role, Dr. Twum‐Danso provided strategic, technical and operational direction to improve MNCH care processes and outcomes at large scale within the NCHS, and the Ghana Health Service, the largest health care provider in Ghana. She led the start‐up of the project, innovation and testing on a small‐scale, and a 10‐fold scale‐up of the most effective process re‐designs and QI capacity‐building of health staff to cover a population of about five million within three years. She later became the Executive Director for African Operations and was responsible for the design, implementation, monitoring and evaluation of other QI projects in Africa and development of new business opportunities.
Before IHI, Dr. Twum‐Danso worked at the Task Force for Global Health in Atlanta, Georgia, USA where she began as an Associate Director for the Mectizan Donation Program for onchocerciasis control and lymphatic filariasis elimination in sub‐Saharan Africa. In March 2006, she became the first Director for Children Without Worms, a public‐private partnership to control soil‐transmitted helminth infections in children in Africa, Asia and Latin America. Her core work at the Task Force focused on strategy, policy, advocacy, program management, serious adverse surveillance and risk management, and partnership development with pharmaceutical companies and governmental, nongovernmental and multilateral agencies at national and international levels to achieve program objectives. Throughout her career, Dr. Twum‐Danso has also served in a technical advisory capacity to several international agencies focused on neglected tropical diseases (African Programme for Onchocerciasis Control,World Health Organization’s Special Programme for Tropical Disease Research, and Pfizer Inc.) and quality improvement (JSI Research and Training Institute and the Expanded Quality Management Using Information Power project).
Dr. Twum‐Danso holds a bachelor’s degree in Biochemical Sciences and a medical degree, both from Harvard University in Cambridge, Massachusetts, USA. She also has a master’s degree in public health with specialization in Health Policy and Management from Emory University in Atlanta. Dr. Twum‐Danso has been a Fellow of the American College of Preventive Medicine since 2003 and is a member of both the American Society of Tropical Medicine and Hygiene and the International Society for Quality in Health Care. She has published 15 papers in peer‐reviewed journals.
Benjamin O. Anderson, MD, FACS
Chair and Director, Breast Health Global Initiative (BHGI)
Full Member, Fred Hutchinson Cancer Research Center
Director, Breast Health Clinic, Seattle Cancer Care Alliance
Professor of Surgery and Global Health Medicine, University of Washington
Benjamin O. Anderson, MD, has been a leading voice in the international breast cancer clinical improvement and best practices movement for the past decade. He founded and chairs the Breast Health Global Initiative (BHGI) with the vision of developing and implementing resource-sensitive, culturally appropriate guidelines for breast cancer early detection, diagnosis and treatment in low- and middle-income countries (LMCs) under the auspices of Fred Hutchinson Cancer Research Center and Susan G. Komen for the Cure®.
As private sector advisor on the U.S. delegation to the 58th World Health Assembly in Geneva, Dr. Anderson contributed to the first World Health Organization Approved Resolution on Cancer Prevention and Control passed in 2005, designed to reinforce comprehensive cancer policies and strategies for LMCs. Dr. Anderson served as president of the American Society of Breast Disease from 2005 to 2007 and has been a member of the board of directors of three national and international academic breast cancer societies. Dr. Anderson has clinical expertise in breast cancer; international breast health care; oncoplastic breast surgery to improve oncologic and cosmetic outcome with complex breast cancer procedures; locally advanced breast cancer; minimally invasive breast diagnosis; and high risk breast health evaluation.
A native of California, he earned his B.A. in mathematics at Pomona College and medical degree at the Albert Einstein College of Medicine in New York City. Following a general surgical residency at the University of Colorado, Dr. Anderson trained in surgical oncology at the Memorial Sloan-Kettering Cancer Center in New York as an American Cancer Society Clinical Oncology Fellow. He joined the surgical faculty at University of Washington in Seattle in 1994 and served as clinical medical director of the breast program from 1998 to 2003. Dr. Anderson continues to serve as director of both the Breast Health Center at the University of Washington and the Breast Health Clinic at the Seattle Cancer Care Alliance, where he has devoted his clinical practice to the care of patients with breast cancer and breast health issues. He holds joint faculty positions in the Fred Hutchinson Cancer Research Center Division of Public Health Sciences and the University of Washington Department of Global Health.
Dr. Anderson was elected by his peers for inclusion in Best Doctors in America in 2001 and has been reelected every year since that time. He received the American Cancer Society Career Development Award for breast cancer research in 1995. Most recently, Dr. Anderson was awarded the 2011 Partners in Progress Award by the American Society of Clinical Oncology (ASCO) for his commitment to women’s health throughout the world and his dedicated efforts to improve their quality of care.